This inventor holds 1 USPTO granted patent. Top assignee: Intrabio Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Grant Charles Churchill and Branched-Chain Amino Acid Derivatives
Introduction
Grant Charles Churchill is an inventor based in Oxford, Great Britain. His patent work includes a pharmaceutical invention concerning branched-chain amino acid derivatives and their potential use in treating disease.
Latest Patents
Churchill is associated with 1 patent, titled “Branched-chain amino acid derivatives to treat disease.” The disclosure describes compounds represented by Formula I, along with pharmaceutically acceptable salts and solvates. It proposes their use to treat or prevent the progression of lysosomal storage disorders and neurodegenerative diseases, provide neuroprotection for people with lysosomal storage disorders, address migraine and associated symptoms, and improve mobility or cognitive function.
Career Highlights
Churchill is associated with Intrabio Limited. His listed patent reflects work at the intersection of medicinal chemistry and potential treatments for neurological and lysosomal disorders.
Collaborations
The available information connects Churchill’s patent work with Intrabio Limited. It does not specify additional collaborators or institutions.
Conclusion
Grant Charles Churchill’s patent focuses on branched-chain amino acid derivatives with proposed applications across several disease areas, including lysosomal storage disorders, neurodegenerative diseases, and migraine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile